| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.003 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.09 | 0.004 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.4 | 0.005 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.088 | 0.006 |